Tag: sleep

Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025

Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025

KeySlim Drops Explores Ingredient-First Weight Management Trends in 2025

A Science-Backed Look at How KeySlim Drops’ Natural Formula Aligns With Evolving Healthy Weight Goals

A Science-Backed Look at How KeySlim Drops’ Natural Formula Aligns With Evolving Healthy Weight Goals

Herz P1 Smart Ring: 24/7 Health Monitoring, Sleep, Stress & Heart Rate Tracking

WuzuTech's Herz P1 Smart Ring: Revolutionizing Wellness with 24/7 Health Monitoring, Real-Time Insights, and Continuous Tracking

WuzuTech's Herz P1 Smart Ring: Revolutionizing Wellness with 24/7 Health Monitoring, Real-Time Insights, and Continuous Tracking

2025 Report: “PurDentix Reviews and Complaints” Surge Reflects Growing Curiosity Around Oral Microbiome Supplements

Consumer Search Data Reveals Expanding Curiosity Around Oral Probiotics and Ingredient Transparency in 2025

Consumer Search Data Reveals Expanding Curiosity Around Oral Probiotics and Ingredient Transparency in 2025

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

INSIDE INFORMATION
REGULATED INFORMATION

Nyxoah Obtient l’Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l’Apnée Obstructive du Sommeil

INFORMATIONS PRIVILÉGIÉES
INFORMATIONS RÉGLEMENTÉES

LionCare: The Future of Wellness with Terahertz Technology for Restful Sleep and Healing in 2025

Experience Groundbreaking Sleep and Cellular Support Backed by Terahertz Innovation, Trusted by Wellness Experts in 2025

Experience Groundbreaking Sleep and Cellular Support Backed by Terahertz Innovation, Trusted by Wellness Experts in 2025

Dogwood Therapeutics Announces Enrollment of First Fifty Patients in Ongoing Halneuron® Phase 2b Trial

- Halneuron^® Chemotherapy-Induced Neuropathic Pain (“CINP”) Phase 2b study interim data readout remains on track as projected for Q4 2025 -

Fullpower-AI Secures 10-Year Global Licensing Agreement and Strategic Investment from Tempur Sealy International to Power the Future of Smartbeds

SANTA CRUZ, Calif., Aug. 7, 2025 /PRNewswire/ -- Fullpower-AI®, a leader in AI-powered health and wellness technologies, today announced a transformative partnership with Tempur Sealy...

Somnigroup International Acquires Equity Interest in Fullpower-AI and Advances Long Term Strategic Partnership

DALLAS, Aug. 7, 2025 /PRNewswire/ -- Somnigroup International Inc. (NYSE: SGI, "Company" or "Somnigroup") today announced the expansion of its relationship with Fullpower-AI® ("Fullpower"),...

A GUINNESS WORLD RECORD… IN QUÉBEC CITY?

QUÉBEC CITY, Aug. 7, 2025 /CNW/ - What if the Capitale-Nationale officially earned a GUINNESS WORLD RECORDS™ title? This year, the Grands Feux Loto-Québec...

THC Gummies Launch in 2025: Delta-9, Sleep, and CBD Hybrid Editions

Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.

 Exhale Wellness introduces new THC gummies in 2025, including Delta-9, Sleep, and CBD hybrid options for flavor, balance, and targeted cannabinoid support.

Saasyan Rolls Out Parent Portal to Help Keep Students Safe Online–At School and Home

SYDNEY, Aug. 7, 2025 /PRNewswire/ -- Saasyan has rolled out its new Parent Portal, now available to schools using its AI-powered student safety solution,...

Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

Modeyso is the first treatment option for this ultra-rare and aggressive brain tumor, which primarily affects children and young adults Accelerated approval based on an...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsSleep

Glacier Breeze Portable AC: Features, Performance Claims & Consumer Feedback Evaluated in 2026

Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation – TBRG

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)